Literature DB >> 21149451

Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.

Jung-Da Fang1, Hsiao-Chin Chou, Hsiu-Hui Tung, Pao-Yi Huang, Sheau-Ling Lee.   

Abstract

Recent studies show that type II transmembrane serine proteases play important roles in diverse cellular activities and pathological processes. Their expression and functions in the central nervous system, however, are largely unexplored. In this study, we show that the expression of one such member, matriptase (MTP), was cell type-restricted and primarily expressed in neural progenitor (NP) cells and neurons. Blocking MTP expression or MTP activity prevented NP cell traverse of reconstituted basement membrane, whereas overexpression of MTP promoted it. The NP cell mobilization induced by either vascular endothelial growth factor or hepatocyte growth factor was also impaired by knocking down MTP expression. MTP acts upstream of matrix metalloproteinase 2 in promoting NP cell mobility. In embryonic stem cell differentiation to neural cells, MTP knockdown had no effect on entry of embryonic stem cells into the neural lineage. High MTP expression or activity, however, shifts the population dynamics from NP cells toward neurons to favor neuronal differentiation. This is the first report to demonstrate the direct involvement of type II transmembrane serine protease in NP cell function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21149451      PMCID: PMC3037680          DOI: 10.1074/jbc.M110.153866

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo.

Authors:  Andrew J Sanders; Christian Parr; Gaynor Davies; Tracey A Martin; Jane Lane; Malcolm D Mason; Wen G Jiang
Journal:  J Exp Ther Oncol       Date:  2006

2.  Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase.

Authors:  Lynette M Kilpatrick; Roger L Harris; Kate A Owen; Rosemary Bass; Christine Ghorayeb; Amit Bar-Or; Vincent Ellis
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

3.  Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain.

Authors:  Ming-Shyue Lee; I-Chu Tseng; Youhong Wang; Ken-ichi Kiyomiya; Michael D Johnson; Robert B Dickson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2007-03-07       Impact factor: 4.249

4.  Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis.

Authors:  Xinlian Jin; Motoki Yagi; Nagisa Akiyama; Tomomi Hirosaki; Shouichi Higashi; Chen-Yong Lin; Robert B Dickson; Hitoshi Kitamura; Kaoru Miyazaki
Journal:  Cancer Sci       Date:  2006-09-25       Impact factor: 6.716

5.  Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway.

Authors:  Ami S Bhatt; Alana Welm; Christopher J Farady; Maximiliano Vásquez; Keith Wilson; Charles S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-27       Impact factor: 11.205

Review 6.  CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain.

Authors:  Ralf Stumm; Volker Höllt
Journal:  J Mol Endocrinol       Date:  2007-03       Impact factor: 5.098

Review 7.  Type II transmembrane serine proteases.

Authors:  Roman Szabo; Qingyu Wu; Robert B Dickson; Sarah Netzel-Arnett; Toni M Antalis; Thomas H Bugge
Journal:  Thromb Haemost       Date:  2003-08       Impact factor: 5.249

8.  Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.

Authors:  E Cacci; M Salani; S Anastasi; I Perroteau; G Poiana; S Biagioni; G Augusti-Tocco
Journal:  J Neurosci Res       Date:  2003-12-01       Impact factor: 4.164

9.  Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.

Authors:  Qiang Xu; Shaoxia Wang; Xijuan Jiang; Yali Zhao; Ming Gao; Yanjun Zhang; Xiaoming Wang; Kaori Tano; Masayuki Kanehara; Wenping Zhang; Torao Ishida
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-07       Impact factor: 2.557

Review 10.  The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system.

Authors:  Clare M Galtrey; James W Fawcett
Journal:  Brain Res Rev       Date:  2007-01-11
View more
  12 in total

1.  Targeting zymogen activation to control the matriptase-prostasin proteolytic cascade.

Authors:  Zhenghong Xu; Ya-Wen Chen; Aruna Battu; Paul Wilder; David Weber; Wenbo Yu; Alexander D Mackerell; Li-Mei Chen; Karl X Chai; Michael D Johnson; Chen-Yong Lin
Journal:  J Med Chem       Date:  2011-10-12       Impact factor: 7.446

2.  Neural transmembrane protease and endothelial Gs protein activation in cell contact-dependent signaling between neural stem/progenitor cells and brain endothelial cells.

Authors:  Hsiu-Hui Tung; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

3.  Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells.

Authors:  Feng-Pai Chou; Han Xu; Ming-Shyue Lee; Ya-Wen Chen; O X Durand Richards; Richard Swanson; Steven T Olson; Michael D Johnson; Chen-Yong Lin
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-27       Impact factor: 4.249

4.  The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide.

Authors:  Erwan Lanchec; Antoine Désilets; François Béliveau; Anthony Flamier; Shaimaa Mahmoud; Gilbert Bernier; Denis Gris; Richard Leduc; Christine Lavoie
Journal:  J Biol Chem       Date:  2017-10-20       Impact factor: 5.157

5.  A recombinant matriptase causes an increase in caspase-3 activity in a small-intestinal epithelial IEC-6 line cultured on fibronectin-coated plates.

Authors:  Seiya Mochida; Satoshi Tsuzuki; Kuniyo Inouye; Tohru Fushiki
Journal:  Cytotechnology       Date:  2013-05-31       Impact factor: 2.058

6.  Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.

Authors:  Joanna Baron; Carolin Tarnow; Deborah Mayoli-Nüssle; Eva Schilling; Daniela Meyer; Maya Hammami; Folker Schwalm; Torsten Steinmetzer; Yi Guan; Wolfgang Garten; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2012-11-28       Impact factor: 5.103

7.  Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.

Authors:  Sauryang Kim; Jae Woong Yang; Chungho Kim; Moon Gyo Kim
Journal:  Oncotarget       Date:  2016-06-07

8.  Physical Binding of Endothelial MCAM and Neural Transmembrane Protease Matriptase-Novel Cell Adhesion in Neural Stem cell Vascular Niche.

Authors:  Hsiu-Hui Tung; Sheau-Ling Lee
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

9.  Hepatocyte growth factor activator inhibitor-1 is induced by bone morphogenetic proteins and regulates proliferation and cell fate of neural progenitor cells.

Authors:  Raili Koivuniemi; Johanna Mäkelä; Marie-Estelle Hokkanen; Céline Bruelle; Tho Huu Ho; Roxana Ola; Laura Korhonen; Jim Schröder; Hiroaki Kataoka; Dan Lindholm
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  Human cancer cells retain modest levels of enzymatically active matriptase only in extracellular milieu following induction of zymogen activation.

Authors:  Li-Ling Chu; Yuan Xu; Jie-Ru Yang; Yi-An Hu; Hsiang-Hua Chang; Hong-Yu Lai; Chun-Che Tseng; Hue-Yu Wang; Michael D Johnson; Jehng-Kang Wang; Chen-Yong Lin
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.